Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1)
- Status
- RECRUITING
- Phase
- PHASE2
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Real World Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab Elovie
- Status
- RECRUITING
- Phase
- N/A
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
- Status
- RECRUITING
- Phase
- N/A
Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer
- Status
- SUSPENDED
- Phase
- EARLY_PHASE1
Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer
- Status
- SUSPENDED
- Phase
- EARLY_PHASE1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)
- Status
- WITHDRAWN
- Phase
- PHASE2
FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2